Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival - Wikidata - wikimedia - TriplyDB

Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival

Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival

http://www.wikidata.org/entity/Q33845555

about

High-risk corneal allografts: A therapeutic challenge Presurgical corticosteroid treatment improves corneal transplant survival in mice Effect of sorafenib in a murine high risk penetrating keratoplasty model Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization.Corneal neovascularization: an anti-VEGF therapy review.Thrombospondin-1 derived from APCs regulates their capacity for allosensitization Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization.Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.Effect of topical azithromycin on corneal innate immune responses.Observation on ultrastructure and histopathology of cornea following femtosecond laser-assisted deep lamellar keratoplasty for acute corneal alkaline burns.Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells.Evaluation of corneal graft survival in mice model.Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone.Inflammatory corneal neovascularization: etiopathogenesis.Gene therapy in corneal transplantation.Proangiogenic Function of T Cells in Corneal Transplantation.Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization.Management of High-risk Corneal Transplantation.Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.Corneal penetration of topical and subconjunctival bevacizumab.Multiquadrant Subtenon Triamcinolone Injection for Acute Corneal Graft Rejection: A Case Report.Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses.Angiogenesis and lymphangiogenesis in corneal transplantation-A review.Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.Kinetics of Angiogenic Responses in Corneal Transplantation.

P2860

Q26751483-96BE089A-0323-4288-83AD-DACAB02A69D2 Q33861559-DAB4E4ED-9240-4123-B350-42B789F8FDDE Q33914667-77730664-E047-4826-9282-FC9B2F631057 Q33961186-71B5118D-1F53-4A19-B6B2-D92CF43DDC1D Q34459026-9C65E4F8-AB25-4575-A148-9C89ABD145A0 Q34511156-1FA2E095-BE56-4982-A826-66452D2A1739 Q34641522-13524C67-CB7C-4062-B77D-399E185DF02E Q34953282-E6303E39-20AD-483D-A1A8-DA4ABF61C244 Q35103846-039EC16B-0E1A-41CD-A428-BB4D5C8EC32A Q35143121-9EAF8D4D-0652-4AC8-BB58-E44F1225FDA2 Q35684022-715C31A8-4E8C-48A1-B750-38955E86FAE1 Q36013008-1F5887AC-3A23-4D75-BC69-56351BF187FC Q36237450-404494BA-2425-48D4-B418-8A74615EE254 Q36571709-5B95766C-BDDA-40FC-9951-A34E356C7370 Q37070754-8FA30480-A068-45F8-8374-A79F1B6C53BD Q37256823-47E0A117-D79A-40A0-8BE9-BFC8E131F2AC Q37716548-483DCC41-52D5-44E9-8874-551959F4C476 Q37940578-3E77736F-7C19-4D5F-8097-0CD29290081A Q38153722-11DFA144-893E-4407-847E-F80ED2CF756D Q38753891-E88B6D49-7BCD-4796-8F09-67A2A6C303D7 Q38755418-8515D68F-28B1-4FC6-9FEF-C1C47597C053 Q38778422-6229C6F5-A3F2-46B8-86D2-5C634824C5B9 Q38904800-1CC2A204-4130-41A4-9BAB-A861C05FC0ED Q39589760-81308F26-E836-4146-89B5-D999B42A1DFA Q42079352-6C30DB70-6614-4201-979B-D94A730C95D0 Q44916496-40EF8870-3405-4B65-AA44-978322B941BE Q47759308-636B5183-C4FC-4F76-B76F-10CD33CBBADF Q50147046-6D74D252-76B2-4573-94C3-69897AAFACC4 Q50968165-7711E423-D81B-4E8B-8999-7AD8125700AE

P2860

Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival

http://www.wikidata.org/entity/Q33845555

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of topical and subconj ...... sk corneal transplant survival

@ast

Effects of topical and subconj ...... sk corneal transplant survival

@en

type

label

Effects of topical and subconj ...... sk corneal transplant survival

@ast

Effects of topical and subconj ...... sk corneal transplant survival

@en

prefLabel

Effects of topical and subconj ...... sk corneal transplant survival

@ast

Effects of topical and subconj ...... sk corneal transplant survival

@en

P1433

Q33845555-45C0BB2B-29DB-481E-A83B-AB8F9B3DF30F

P1476

Q33845555-4D0D422D-3B63-41E6-ABBA-55863E02CC35

P2093

Q33845555-01C4A175-E930-49EE-A91E-3E180795B0D9

Q33845555-45BE6C32-2756-4761-809F-A178B6A36E03

Q33845555-4A77986E-C8C0-4E83-933B-203005D428C0

Q33845555-7BA8EF60-2145-473C-BC9E-07B1F936B416

Q33845555-80E9A675-8C1B-4D68-9CE9-7DBDD8962B43

Q33845555-ACF0C269-BD4A-42E6-8B35-9D32C85E885F

Q33845555-B9BD6424-B694-4C29-900D-FCE6B5940044

Q33845555-FD242CD5-0544-4708-B85C-1FB1634B54F2

P2860

Q33845555-01DF03D1-D5B0-4B32-B987-A2689F7860A9

Q33845555-046CD21D-5A4E-48D2-B9A2-B66A4F7D9085

Q33845555-057D079D-2CF1-4354-9432-4F66F12AC658

Q33845555-0A5CF804-F179-4D6C-94DB-8653572EA057

Q33845555-0AF6F90C-BD58-4060-9E51-B4B12EC60918

Q33845555-1BF16F7A-39C7-4621-AF7F-B9EB9AB9A924

Q33845555-211AA769-7AFD-4415-80AD-DDD43C975345

Q33845555-477C546A-12BD-4330-830F-80AADD284642

Q33845555-486F900C-9405-45F5-9339-43125F685C2B

Q33845555-4DA46BFB-A10A-4F9F-AFF9-AA12C9990191

P304

Q33845555-AF20865A-A41A-4638-8534-72375341BC3F

P31

Q33845555-E058D4D0-914B-4A83-A384-99A7431C6B2D

P356

Q33845555-13246D04-1070-4E23-94EE-5BF675D59140

P407

Q33845555-C3CDA13A-0100-4F2D-99FF-8DA638893F9A

P433

Q33845555-C669AC9C-0E9A-49AC-8602-11302007C120

P478

Q33845555-F7BA0DEB-FF35-412B-BF35-D81A4DC3CCD1

P577

Q33845555-522DA1F8-9E7B-4DAE-89D8-1AC08E74C4F0

P5875

Q33845555-4CE1E91E-BAB0-48FA-8273-4DC75C705BB9

P698

Q33845555-CAD0F90A-7E7B-4FD5-A969-D7977FA1393F

P921

Q33845555-F84EB2E4-C9CD-4B20-BB7D-632BDEE0D408

P932

Q33845555-E5ED4B0A-C02A-42C2-9172-ED4311CCF5E7

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Effects of topical and subconj ...... sk corneal transplant survival

@en

P2093

Amir R Hajrasouliha

http://www.w3.org/2001/XMLSchema#string

Andre Okanobo

http://www.w3.org/2001/XMLSchema#string

Daniel R Saban

http://www.w3.org/2001/XMLSchema#string

Mohammad H Dastjerdi

http://www.w3.org/2001/XMLSchema#string

Nambi Nallasamy

http://www.w3.org/2001/XMLSchema#string

Reza Dana

http://www.w3.org/2001/XMLSchema#string

Sunil K Chauhan

http://www.w3.org/2001/XMLSchema#string

Zahra Sadrai

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenesis in cancer, vascular, rheumatoid and other disease

Corneal neovascularization.

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

Interaction between bevacizumab and murine VEGF-A: a reassessment.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.

Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization.

Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.

P304

2411-2417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.09-3745

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38070358

http://www.w3.org/2001/XMLSchema#string

P698

19892863

http://www.w3.org/2001/XMLSchema#string

P921

P932

2868492

http://www.w3.org/2001/XMLSchema#string